Shockwave’s novel Javelin intravascular lithotripsy catheter focuses acoustic energy forward to clear a path through calcium-clogged blood vessels.

The Javelin Peripheral IVL catheter features new technology for modifying calcium and crossing extremely narrowed vessels in patients with peripheral artery disease (PAD).
Shockwave says the novel, non-balloon IVL platform delivers a similar safety and efficacy profile as its legacy catheters, bolstering the device developer’s market-leading IVL portfolio.
“We believe this technology has the ability to transform the way that physicians are able to treat patients with peripheral vascular disease,” Shockwave Chief Medical Officer Dr. Nick West said in a Medical Design & Outsourcing interview. “We hope that we’re answering a clear unmet need not just from physicians, but from the patients they also serve.”